Granata Bio

Granata Bio

  • Founded: 2018
  • Location: Duxbury, MA
  • Employee range: 1 - 10
  • Clinical stage: COM
  • Therapy area: Hormonal control in fertility treatments
  • Drug types: OBG, IMM
  • Lead product: Ganirelix Acetate (partner: Amphastar)
  • Product link:

job board

Short description:

Fertility Treatments

Drug notes:

Milophene COM ovulation induction; Progesterone-IBSA Clin3 infertility (partner: IBSA); GB-hMG RD/Clin0? Infertility

Long description:

Granata Bio is identifying and developing therapies that can help fertility patients. The biggest barrier to fertility treatment in the US is cost with the price for IVF treatments rising 50% since 2014. Granata’s model is to identify and in-license strategic medications used in IVF outside of the US for clinical development and commercialization in North America. Currently, Granata has five drug programs in their pipeline that are either already commercially available or are in late-stage clinical trials.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy